{
    "clinical_study": {
        "@rank": "99405", 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the potential interactions between intravenous (IV)\n      cocaine and tolcapone."
        }, 
        "brief_title": "Assessment of Potential Interactions Between Cocaine and Tolcapone - 1", 
        "completion_date": "March 2002", 
        "condition": "Cocaine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "Double-blind, inpatient study by screening responses to cocaine infusions of 20 and 40 mg\n      i.v. subjects into 1 of 2 treatment groups to assess potential interactions between i.v.\n      cocaine infusion and treatment with tolcapone."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Volunteers dependent on cocaine and are non-treatment seeking; between 18-45 yrs of age;\n        DSM-4 criteria for cocaine abuse or dependence\n\n        Exclusion Criteria:\n\n        Additional criteria available during screening at the site"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "16", 
        "firstreceived_date": "April 5, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT00024765", 
            "nct_id": "NCT00033059", 
            "org_study_id": "NIDA-CTO-0003-1"
        }, 
        "intervention": {
            "intervention_name": "Tolcapone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Tolcapone"
        }, 
        "lastchanged_date": "February 8, 2007", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90024"
                }, 
                "name": "UCLA Integrated Substance Abuse Program"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Assessment of Potential Interactions Between Intravenous Cocaine and Tolcapone", 
        "overall_official": {
            "affiliation": "National Institute on Drug Abuse (NIDA)", 
            "last_name": "Thomas Newton, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "primary_outcome": {
            "measure": "Safety"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00033059"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "July 2001", 
        "study_design": "Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2003"
    }, 
    "geocoordinates": {
        "UCLA Integrated Substance Abuse Program": "34.052 -118.244"
    }
}